Revista de Medicina Interna. AMICAC.


Año VII. 2015 No.4

Mes Abril 2015

Management of acute aortic dissection Christoph A Nienaber, Rachel E Clough.
A new appraisal of the management of acute aortic dissection is timely because of recent developments in diagnostic strategies (including biomarkers and imaging), endograft design, and surgical treatment, which have led to a better understanding of the epidemiology, risk factors.........

Performance of Four Current Risk Algorithms in Predicting Cardiovascular Events in Patients With Early Rheumatoid Arthritis.
Areas under the receiver operating characteristic curve were 0.78–0.80, indicating moderate to good discrimination between patients with and without a CV event. The CV risk models Systematic Coronary Risk Evaluation (SCORE), Framingham risk score (FRS) and Reynolds risk score (RRS) primarily underestimated CV risk at.....

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis Nanna B Finnerup*, Nadine Attal*, Simon Haroutounian, Ewan McNicol, Ralf Baron, Robert.
229 studies were included in the meta-analysis. Analysis of publication bias suggested a 10% overstatement of treatment eff ects. Studies published in peer-reviewed journals reported greater eff ects than did unpublished studies (r² 9·3%, p=0·009). .....
Effect of Varenicline on Smoking Cessation Through Smoking Reduction A Randomized Clinical Trial Jon O.Ebbert, MD, MSc; JohnR. Hughes
Randomized, double-blind, placebo-controlled, multinational clinic altrial with a 24-week treatment periodand 28-week follow-up conducted between July 2011 and July 2013 at 61 centersin 10 countries.........
Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial Anna Axelsson, Kasper Iversen.
Between Dec 1, 2011, and May 1, 2013, 318 patients were screened. 133 patients (mean age 52 years [SD 13], 35% women) consented and were randomly assigned to placebo (n=69) or losartan (n=64). 124 (93%) patients completed the study ......
La pandemia de obesidad: últimos descubrimientos científicos y estrategias clínicas novedosas.
A pesar de que la obesidad puede evitarse, se ha calculado que en 2014 más de 600 millones de adultos del mundo entero serán obesos y que 1,9 millones de personas tendrán sobrepeso, lo que constituye aproximadamente el 30 % de la población mundial.[1-3] El sobrepeso y la obesidad se producen